Simultaneous Estimation of Empagliflozin and Metformin by High-Performance Thin-Layer Chromatography Using Quality-by-Design Approach
Abstract
The present research work highlights the benefits of analytical quality-by-design (QbD) approach to optimize high-performance thin-layer chromatography (HPTLC) method for the simultaneous quantification of empagliflozin and metformin in fixed dose combination. With a QbD model, the present study endeavors to establish the method operable design region (MODR) for optimization of the HPTLC method assay by means of design of experiments (DOE) and response surface methodology, in order to achieve a good separation and quantification of all analyzed compounds along with an acceptable analysis time. A deep understanding of the quality target product profile (QTPP) and of the analytical target profile (ATP), followed by a risk assessment for variables that affect the efficiency of the method, led to the development of a precise, accurate, and cost-effective method. The method was established on pre-coated silica gel 60 F254 aluminum plates using ammonium acetate (2%)—methanol—acetonitrile—ethyl acetate (3:1:4.5:1.5) as the mobile phase at a detection wavelength of 228 nm. Numerical optimization was performed using the Derringer’s desirability approach and ANOVA to develop optimized chromatography. The RF values were 0.49 and 0.81 for metformin and empagliflozin, respectively. The limits of detection for empagliflozin and metformin were found to be 3.49 ng per band and 109.7 ng per band, respectively, while the limits of quantification for empagliflozin and metformin were found to…
Read the paper
Related studies
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
- Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
- Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
- Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease—From Bench to Bedside
- Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
- Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.